NYSEArca - Nasdaq Real Time Price USD

SPDR S&P Pharmaceuticals ETF (XPH)

39.45 +0.36 (+0.92%)
As of 11:50 AM EDT. Market Open.

Top 10 Holdings (46.53% of Total Assets)

SymbolCompany% Assets
AXSM
Axsome Therapeutics, Inc. 4.87%
MRK
Merck & Co., Inc. 4.82%
PRGO
Perrigo Company plc 4.73%
ITCI
Intra-Cellular Therapies, Inc. 4.63%
JAZZ
Jazz Pharmaceuticals plc 4.62%
LLY
Eli Lilly and Company 4.61%
PFE
Pfizer Inc. 4.60%
OGN
Organon & Co. 4.60%
BMY
Bristol-Myers Squibb Company 4.55%
RPRX
Royalty Pharma plc 4.51%

Sector Weightings

SectorXPH
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.80%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.06
Price/Book 0.41
Price/Sales 0.4
Price/Cashflow 0.09
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

ETF Overview

Category Health
Fund Family SPDR State Street Global Advisors
Net Assets 219.96M
YTD Daily Total Return -5.69%
Yield 1.37%
Legal Type Exchange Traded Fund

Related Tickers